Total Payments
$197.69
2023 Payments
$73.19
Companies
4
Transactions
11

Payment Breakdown by Category

Food & Beverage$197.69 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $197.69 11 100.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $74.02 4 $0 (2023)
Sobi, Inc $59.32 3 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $51.07 3 $0 (2022)
Supernus Pharmaceuticals, Inc. $13.28 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $73.19 4 Merck Sharp & Dohme LLC ($59.91)
2022 $61.68 3 Sobi, Inc ($42.68)
2021 $62.82 4 Takeda Pharmaceuticals U.S.A., Inc. ($32.07)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/06/2023 Merck Sharp & Dohme LLC VAXNEUVANCE (Biological), GARDASIL 9, VAXELIS Food and Beverage In-kind items and services $25.70 General
Category: INFECTIOUS DISEASE
08/24/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $13.28 General
Category: PSYCHOLOGY
04/12/2023 Merck Sharp & Dohme LLC GARDASIL 9 (Biological) Food and Beverage In-kind items and services $19.69 General
Category: VACCINE
02/01/2023 Merck Sharp & Dohme LLC VAXELIS (Biological), VAXNEUVANCE, GARDASIL 9 Food and Beverage In-kind items and services $14.52 General
Category: VACCINE
08/17/2022 Sobi, Inc SYNAGIS (Drug) Food and Beverage In-kind items and services $29.09 General
Category: IMMUNOLOGY
04/20/2022 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $19.00 General
Category: NEUROSCIENCE
02/02/2022 Sobi, Inc SYNAGIS (Drug) Food and Beverage In-kind items and services $13.59 General
Category: IMMUNOLOGY
12/08/2021 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $14.35 General
Category: NEUROSCIENCE
08/18/2021 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $17.72 General
Category: NEUROSCIENCE
07/28/2021 Sobi, Inc SYNAGIS (Drug) Food and Beverage In-kind items and services $16.64 General
Category: IMMUNOLOGY
06/23/2021 Merck Sharp & Dohme Corporation GARDASIL 9 (Biological), ROTATEQ, VAQTA Food and Beverage In-kind items and services $14.11 General
Category: VACCINE

About Dr. Sonia Murickananil, M.D

Dr. Sonia Murickananil, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1811425952.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonia Murickananil, M.D has received a total of $197.69 in payments from pharmaceutical and medical device companies, with $73.19 received in 2023. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($197.69).

Practice Information

Products in Payments

  • SYNAGIS (Drug) $59.32
  • VYVANSE (Drug) $51.07
  • GARDASIL 9 (Biological) $33.80
  • VAXNEUVANCE (Biological) $25.70
  • VAXELIS (Biological) $14.52
  • QELBREE (Drug) $13.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Staten Island